Feedback plc (AIM:FDBK)
London · Delayed Price · Currency is GBP · Price in GBX 14.40
+2.05 (16.60%)
Apr 17, 2026, 4:28 PM GMT
Feedback Market Cap
Feedback has a market cap or net worth of 6.31 million as of April 17, 2026. Its market cap has decreased by -14.79% in one year.
Market Cap
6.31M
Enterprise Value
2.49M
Revenue
849.62K
Ranking
n/a
PE Ratio
n/a
Stock Price
14.40
Market Cap Chart
Since May 30, 1997, Feedback's market cap has increased from 1.70M to 6.31M, an increase of 271.93%. That is a compound annual growth rate of 4.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 5.41M | 28.31% |
| Dec 31, 2025 | 4.22M | -47.26% |
| Dec 31, 2024 | 8.00M | -11.16% |
| Dec 29, 2023 | 9.00M | -30.77% |
| Dec 30, 2022 | 13.00M | -44.29% |
| Dec 31, 2021 | 23.34M | 103.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 230.51B |
| GSK plc | 84.81B |
| Haleon | 31.43B |
| Smith & Nephew | 10.69B |
| CRISM Therapeutics | 6.08M |
| OptiBiotix Health | 5.47M |
| Proteome Sciences | 5.26M |
| Theracryf | 5.16M |